✦ LIBER ✦

Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia

✍ Scribed by Raul Gómez; Antonio Abad; Francisco Delgado; Silvia Tamarit; Carlos Simón; Antonio Pellicer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of the dopamine agonists bromocripti

✍ Tollin, Steven R. 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 79 KB

Evidence for the Partial Dopamine-Recept

✍ Zachary S. Hoffer; Richard L. Roth; Maju Mathews 📂 Article 📅 2009 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 115 KB

Effects of sustained hyperprolactinemia

✍ Fabio Benfenati; Carlo Ferretti; Mauro Cimino; Guido Vantini; Maria Lipartiti; G 📂 Article 📅 1986 🏛 Elsevier Science ⚖ 680 KB

The effect of aripiprazole and quinagoli

✍ Rosalie Broekhof; Manon J. Gosselink; Hanno Pijl; Erik J. Giltay 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 393 KB

P-166 The effect of GnRH agonist suppres

✍ A Caruso; R.G Rawlins; E Radwanska 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 275 KB

Effects of Long-Term Bromocriptine Treat

✍ Werner, S. ;Brismar, K. ;Freyschuss, U. 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) ⚖ 420 KB